Novelrad

Minimally-invasive Suturing for Vascular and Heart Defect Closure

Health Tech & Life Sciences
Active
Pre-Funding Metzer, Israel Founded 2019
Website ↗ LinkedIn
Last updated 2026-06-18
Total raised
—
Last: Grant 2024-02
Stage
Pre-Funding
Founded
2019
Headcount
10
HQ
Metzer, Israel
Sector
Health Tech & Life Sciences

About

Novelrad has developed a micro sewing machine that can deploy a range of continuous suture patterns, percutaneously, with a simple click of a button. The versatile suturing platform mimics the surgical ‘gold standard’ and can address multiple indications in the cardiovascular system and beyond.

The device deploys a multipoint purse string suture at the beginning of the procedure, thereby, enabling safe dilation and reliable closure at the end of the procedure.

The Novelrad VCD features an unprecedented range of bore sizes using a single device.

Funding history · 1 round · — total

2024-02
Grant Undisclosed
EIC Accelerator

Q&A

What is Novelrad's primary focus?
Novelrad specializes in minimally-invasive suturing for vascular and heart defect closure, utilizing a micro sewing machine that can deploy continuous suture patterns percutaneously.
When was Novelrad founded?
Novelrad was founded in January 2019.
What was Novelrad's most recent funding round?
In February 2024, Novelrad received a Grant from EIC Accelerator.
Who are the co-founders of Novelrad?
The co-founders of Novelrad are Netanel Sharabani, who serves as Co-founder & CEO, and Ori Goldor, who is the Co-founder & R&D Manager.
What sector does Novelrad operate in?
Novelrad operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.
Where is Novelrad headquartered?
Novelrad is headquartered in Metzer, Israel.

Team · 2

Netanel Sharabani
Founder · Co-founder & CEO
LinkedIn ↗
Ori Goldor
Founder · Co-founder & R&D Manager
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Tags

medical-devicessurgeonsvascularsurgery-tools
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)